SCHEMBL12219

SCHEMBL12219

O=C1CC[C@@H](C(=O)O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12212 1.00
SCHEMBL12268 1.00
Hydrochloric Acid SCHEMBL1372283 0.98 CA1 (0.43)
Iodide SCHEMBL10698321 0.98 CA1 (0.43)
Hydrochloric Acid SCHEMBL1372279 0.98 CA1 (0.43)
SCHEMBL9846779 0.86 CA1 (0.37)
SCHEMBL18302606 0.86 CA1 (0.37)
SCHEMBL5884221 0.85 LMNA (0.41)
SCHEMBL14249431 0.85 POLB (0.39)
SCHEMBL27920507 0.83 CA1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 688 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
US-20250187998-A1 IDENTIFICATION OF SOIL BACTERIA-ENRICHING AGENTS AND METHODS OF USE THEREOF CALIFORNIA INSTITUTE OF TECHNOLOGY 2025-06-12 US claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
US-11999741-B2 Process for the synthesis of 6-((3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-3-(tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one CARDURION PHARMACEUTICALS, INC. (US) 2024-06-04 US claimed
US-11760750-B1 Process for preparing levoketoconazole NURAY CHEMICALS PRIVATE LIMITED (IN) 2023-09-19 US claimed
US-20230122169-A1 NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE CELLTRION, INC. (KR) 2023-04-20 US claimed
CN-110573495-B Trans-isomeric heterocyclic compounds and process for preparing same 浙江医药股份有限公司新昌制药厂 2023-04-11 CN claimed
EP-3858816-A1 NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE Celltrion, Inc. (KR) 2021-08-04 EP claimed
CN-112739686-A Novel process for the preparation of (-) -xylometazoline succinate 赛特瑞恩股份有限公司 2021-04-30 CN claimed
WO-2020067683-A1 NOVEL PROCESS FOR THE PREPARATION OF (+)-CIBENZOLINE SUCCINATE CELLTRION INC. (KR) 2020-04-02 WO claimed
US-20040029923-A1 Organic acid salt of amlodipine CJ CORPORATION (KR) 2004-02-12 US claimed
WO-2003093259-A1 OPTICALLY ACTIVE β-AMINOKETONES, OPTICALLY ACTIVE 1,3-AMINOALCOHOLS AND METHOD FOR THE PRODUCTION THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-11-13 WO claimed
EP-0725651-B1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1999-08-11 EP claimed
US-5652219-A Hemoregulatory peptides SMITHKLINE BEECHAM CORPORATION (US) 1997-07-29 US claimed
EP-0621788-A4 HEMOREGULATORY PEPTIDES. SMITHKLINE BEECHAM CORP (US) 1997-03-05 EP claimed
EP-0725651-A4 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1997-03-05 EP claimed
EP-0725651-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1996-08-14 EP claimed
WO-1995011693-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1995-05-04 WO claimed
EP-0621788-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-11-02 EP claimed
WO-1993013789-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1993-07-22 WO claimed